Shares of GSK can be purchased through any online brokerage account. The P/E ratio of GlaxoSmithKline is 11.04, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.82. GlaxoSmithKline plc (NYSE:GSK) released its quarterly earnings results on Wednesday, July, 29th. Based on an average daily trading volume, of 2,870,000 shares, the days-to-cover ratio is presently 4.0 days. GSK Payout Ratio GSK Price Forecast Based on Dividend Discount Model. PEG Ratios above 1 indicate that a company could be overvalued. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Glaxosmithkline Plc Ord 25P Upcoming Financial Events. GlaxoSmithKline plc . GSK Ex-Dividend Date 2020 August 13. There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 1.5. GSK announces the following dividend dates for 2020. View all competitors. GlaxoSmithKline has a PEG Ratio of 2.73. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. View analyst ratings for GlaxoSmithKline. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 62.99% next year. The next British American Tobacco Plc dividend went ex 11 days ago for 52.6p and will be paid in 1 month. This page reports . Vote “Underperform” if you believe GSK will underperform the S&P 500 over the long term. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Learn more. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. GlaxoSmithKline (NYSE:GSK) declares GBP 0.19/share quarterly dividend, in line with previous.. Yield TTM 4.87%. The pharmaceutical company reported $0.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by $0.01. It pays a dividend yield of 5.17%, putting its dividend yield in the top 25% of dividend-paying stocks. View GlaxoSmithKline's earnings history. These dates are indicative and may be subject to change. GlaxoSmithKline has received 59.35% “underperform” votes from our community. View which stocks have been most impacted by COVID-19. GlaxoSmithKline plc also has a joint research collaboration with Fimbrion Therapeutics Inc. to develop a small molecule candidate for the treatment and prevention of urinary tract infections. Q4 2020 Ex-dividend date amended to 18 February 2021. The previous British American Tobacco Plc dividend was 52.6p and it went ex 3 months ago and it was paid 2 months ago. The official website for GlaxoSmithKline is www.gsk.com. The dividend payout ratio of GlaxoSmithKline is 61.20%. $0.4929. All rights reserved. GlaxoSmithKline has a P/B Ratio of 3.96. View our full suite of financial calendars and market data tables, all for free. Receive a free world-class investing education from MarketBeat. Dividends are common dividends paid per share, reported as of the ex-dividend date. Identify stocks that meet your criteria using seven unique stock screeners. View which stocks are hot on social media with MarketBeat's trending stocks report. The following amendment has been made to the 'GSK publishes 2020 Dividend Dates' announcement released on 8 January 2020 at 15:11 under RNS No 1969Z. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. GSK publishes provisional dividend dates . All other details remain unchanged. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. GlaxoSmithKline has only been increasing its dividend for 1 years. Get daily stock ideas top-performing Wall Street analysts. In the past three months, GlaxoSmithKline insiders have bought more of their company's stock than they have sold. GlaxoSmithKline declared a quarterly dividend on Thursday, July 30th. It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology; and strategic alliance with Merck KGaA to jointly develop and commercialize M7824 (bintrafusp alfa), an investigational bifunctional fusion protein immunotherapy. Some companies that are related to GlaxoSmithKline include Roche Holdings AG Basel (RHHBY), Pfizer (PFE), Merck & Co., Inc. (MRK), Novartis (NVS), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), AbbVie (ABBV), Eli Lilly And Co (LLY), AstraZeneca (AZN), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), Sanofi (SNY), Commonwealth Bank of Australia (CSLLY), Zoetis (ZTS) and Celgene (CELG). Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020. Shareholders of record on Friday, August 14th will be given a dividend of $0.4914 per share on Thursday, October 8th. In general, profits from business operations can be allocated to retained earnings or paid to shareholders in the form of dividends or stock buybacks. Looking for new stock ideas? Glaxosmithkline Financial Calendar. The pharmaceutical company can be reached via phone at 44-20-8047-5000 or via email at [email protected]. The pharmaceutical company had revenue of $9.46 billion for the quarter, compared to the consensus estimate of $9.60 billion. Learn more. GlaxoSmithKline updated its FY 2020 GSK Dividend Yield 5.16% GSK Annual Dividend $1.94 . Top institutional investors include Envestnet Asset Management Inc. (0.04%), 10 15 Associates Inc. (0.01%), Farmers Trust Co. (0.01%), Ipswich Investment Management Co. Inc. (0.00%), Old Port Advisors (0.00%) and Avantax Advisory Services Inc. (0.00%). There are currently 3 sell ratings, 3 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View insider buying and selling activity for GlaxoSmithKline. Vote “Outperform” if you believe GSK will outperform the S&P 500 over the long term. One share of GSK stock can currently be purchased for approximately $37.21. Dividend Definition. {{ storiesRelated.scrollNewsPercent }}% Complete, Just Eat Takeaway delivers tasty rise in order growth, MJ Hudson acquires Ireland-based Bridge Group, London close: Stocks mixed as investors look to Europe summit, London midday: Stocks slip into the red as sterling steadies, GSK publishes provisional 2020 Dividend Dates, US close: Stocks finish lower as investors sift through earnings, Europe close: Stocks end on mixed note ahead of key EU leaders' summit, Thursday preview: EU summit, Schroders in the spotlight, Director dealings: Bigblu director makes share purchase via Harwood Capital, Broker tips: Hammerson, Diploma, Go-Ahead, Stagecoach, Touchstone upbeat after completing Chinook-1 well, FTSE 250 movers: Kainos surges; FirstGroup hit by downgrade, System1 reports 'marked reduction' in sales. GlaxoSmithKline had a return on equity of 31.21% and a net margin of 19.03%. For further information, please contact rns@lseg.com or visit www.rns.com. Earnings for GlaxoSmithKline are expected to grow by 2.33% in the coming year, from $3.01 to $3.08 per share. These dates are indicative and may be subject to change. Only 10.00% of the stock of GlaxoSmithKline is held by insiders. View insider buying and selling activity for GlaxoSmithKline. View keys dates for earnings releases, dividends and other company events. GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. You are seeing these quotes based on previous browsing related to sectors such as. If investors simply purchase the security prior to the ex-dividend date and then sell it either on the ex-dividend date or at some point afterward, they will be able to receive the dividend in their account. Past Earnings. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Q4 2020 Ex-dividend date amended to 18 February 2021. The following amendment has been made to the 'GSK publishes 2020 Dividend Dates' announcement released on 8 January 2020 at 15:11 under RNS No 1969Z. Learn everything you need to know about successful options trading with this three-part video course. As of 07 Oct 2020 no upcoming dividend payment date has been declared for a company with EPIC 'GSK' 08 January 2020 . The company was founded in 1715 and is headquartered in Brentford, the United Kingdom. There are no upcoming events for GSK. GlaxoSmithKline's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. Want to see which stocks are moving? Obtains access to the information in a personal capacity; Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so; Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds; Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes. GlaxoSmithKline saw a increase in short interest during the month of September. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Please log in to your account or sign up in order to add this asset to your watchlist. Only 12.12% of the stock of GlaxoSmithKline is held by institutions. Specifically, they have bought $6,499,998.00 in company stock and sold $0.00 in company stock. GlaxoSmithKline employs 99,437 workers across the globe. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA).